Indian Immunologicals launches a pentavalent vaccine

| By | Development of Vaccines, India

Indian Immunologicals Ltd. (IIL) has launched Vaxtar 5, a pentavalent vaccine for children. Developed with the company’s research and development expertise, it will be made at the IIL’s vaccine manufacturing facility in Hyderabad for retail market as well as the national Universal Immunisation Programme implemented by the Union Ministry of Health and Family Welfare.

Vaxtar 5, that will offer protection against Diptheria, Pertussis, Tetanus, Hepatitis B and HiB, has been tested in multiple centres under prescribed government guidelines, the company said on Tuesday. The vaccine is available in single and multidose presentations.

The Ministry, which had introduced pentavalent vaccine four years ago, procures about 85 to 90 million doses annually and is in the process of scaling up the use across the country.

In a recent tender floated by the Ministry for pentavalent vaccine, IIL emerged as the most competitive bidder. A wholly owned subsidiary of National Dairy Development Board, the company had launched several other human vaccines in the past decade and supplying its Hepatitis B, DPT (Triple Antigen) and TT (Tetanus Toxoid) vaccines to UIP. It is also working on hexavalent vaccine which includes inactivated polio antigen, the release said.

SOURCE: hindu
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.